HOME COMPANY TECHNOLOGY PATIENTS CLINICAL TRIAL MEDIA INVESTORS PROFESSIONALS CONTACT US PATIENTS AT THE CENTER OF INNOVATION ... CLOSE SEE ALSO TESTIMONY OF PATIENTS IN CLINICAL TRIALS NEWS AND EVENTS 05/10/2016 - RETINA TODAY : RESTORING VISUAL FUNCTION WITH A BIONIC RETINAL IMPLANT: MISSION IM?POSSIBLE? "Artificial bionic vision technology offers promising results, but postimplantation re-education and training are needed to provide more meaningful visual perception. Hope and expectations remain high on the frontier of neuroscience and neurooph 18/09/2016 - RACONTEUR - DEVELOPMENTS IN RETINAL IMPLANTS GIVE HOPE TO THOSE WITH SIGHT LOSS Clinical trials are underway in the UK for a new ?bionic? vision system with the potential to restore vision in patients with sight loss. Following approval from the Medicines and Healthcare products Regulatory Agency, clinical trials of the Iri 18/09/2016 - BIONIC VISION WILL CHANGE CONCEPTS OF SIGHT Technological innovations are revolutionising eyecare and giving hope to millions with lost or impaired sight.The second Moorfields project is part of a European multi-centre trial with the IRIS Bionic Vision System that uses a special camera, proces PUBLICATIONS 29/09/2016 - PIXIUM VISION ANNOUNCES AN 11 MILLION EUROS BOND FINANCING FACILITY 12/09/2016 - PIXIUM VISION RECEIVES CLINICAL TRIAL APPROVAL FROM SPANISH MINISTRY OF HEALTH FOR 150 ELECTRODE IRIS®II BIONIC VISION SYSTEM 25/07/2016 - PIXIUM VISION ANNOUNCES CE MARKET APPROVAL OF IRIS®II, ITS FIRST BIONIC VISION SYSTEM Twitter @PixiumVision Pixium Vision shares are eligible for the French tax incentivized PEA-PME and FCPI investment vehicles. Pixium Vision shares are eligible for the French tax incentivized PEA-PME and FCPI investment vehicles. COMPANY About Pixium Vision Management Board of Directors Scientific & Medical Commitee Partners TECHNOLOGY Technology Bionic VRS Technology Smart Bioinspired Neuromorphic (Event-Based) Camera IRIS® Bionic Vision Restoration System PRIMA Bionic Vision Restoration System PATIENTS Overview Blindness Retinitis Pigmentosa (RP) Age-related macular degeneration (AMD) Useful Links CLINICAL TRIAL Overview Evaluation Criteria Inclusion Criteria Participating Centers Testimonials Contact MEDIA Press Releases In the News Events Publications Press Kit INVESTORS Letter from the Chairman Share Information Press Releases Conferences Financial Reports and Documents Broker research Other Regulated Information Analyst Coverage Shareholder's General Meeting Financial Calendar Contact PROFESSIONALS Technology Indications Clinical trial CONTACT US Contact us Job opportunities © COPYRIGHT PIXIUM VISION. ALL RIGHTS RESERVED. | LEGAL INFORMATION | DESIGN : AGENCE K2